Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000568541

Apexbio Technology LLC GNE-7883-10MG
SDP

Catalog No. 5000568541
Encompass_Preferred

GNE-7883 (CAS No 2648450-42-2) is a novel compound in the category of targeted cancer therapeutics It originates from advanced pharmaceutical research focused on inhibiting specific molecular pathways involved in tumor growth The mechanism of action primarily involves the blockade of key signaling pathways which are crucial for cancer cell proliferation and survival In vitro studies suggest that GNE-7883 exhibits potent inhibition in the nanomolar to low micromolar range indicating significant efficacy across various cancer cell lines This compound is commonly used in preclinical settings including cell models and animal studies to evaluate its potential as an anticancer agent It also plays a critical role in drug screening processes aimed at identifying new therapeutic candidates Experimental concentrations for GNE-7883 typically depend on the specific research design allowing for flexibility in dosage based on desired outcomes in different experimental setups

Catalog No. 50-005-68541 Supplier Apexbio Technology LLC Supplier No. BA912210
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GNE-7883 (CAS No 2648450-42-2) is a novel compound in the category of targeted cancer therapeutics It originates from advanced pharmaceutical research focused on inhibiting specific molecular pathways involved in tumor growth The mechanism of action primarily involves the blockade of key signaling pathways which are crucial for cancer cell proliferation and survival In vitro studies suggest that GNE-7883 exhibits potent inhibition in the nanomolar to low micromolar range indicating significant efficacy across various cancer cell lines This compound is commonly used in preclinical settings including cell models and animal studies to evaluate its potential as an anticancer agent It also plays a critical role in drug screening processes aimed at identifying new therapeutic candidates Experimental concentrations for GNE-7883 typically depend on the specific research design allowing for flexibility in dosage based on desired outcomes in different experimental setups

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.